Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Am J Obstet Gynecol. 2011 Jun 15;205(3):249.e1–249.e8. doi: 10.1016/j.ajog.2011.06.024

Table 3.

Vaginal Colonization

# mice colonized with GBS
Vaccine
Formulation
Dose Route Ia (p-value) III (p-value) V (p-value) Total (p-value)
75:25 0ug IM 3/5 (n/a) 2/5 (n/a) 3/5 (n/a) 8/15 (n/a)
75:25 10ug IM 3/5 (1) 2/5 (1) 2/5 (0.58) 7/15 (1)
75:25 30ug IM 0/5 (0.16) 0/5 (0.16) 3/5 (1) 3/15 (0.07)
50:50 30ug IM 0/5 (0.16) 0/5 (0.16) 4/5 (0.54) 4/15 (0.27)
free C5a peptidase 30ug IM 3/5 (1) 5/5 (0.08) 3/5 (1) 11/15 (0.45)
75:25 0ug IN 4/5 (n/a) 2/5 (n/a) 4/5 (n/a) 10/15 (n/a)
75:25 10ug IN 1/5 (0.21) 2/5 (1) 2/5 (0.29) 5/15 (0.08)
75:25 30ug IN 1/5 (0.21) 1/5 (1) 2/5 (0.29) 4/15 (0.06)
50:50 30ug IN 2/5 (0.29) 1/5 (1) 1/5 (0.21) 4/15 (0.06)
free C5a peptidase 30ug IN 3/5 (0.58) 3/5 (1) 4/5 (1) 10/15 (1)

p-values represent 2-tailed Fisher exact comparing the 75:25 0ug dose of each route of administration against each of the other vaccination groups.